Evidence map›Paper›PMID 40004957›Full record

ArticleNutrients2025

Positive and Negative Expectations Associated with Coffee and Energy Drinks: Implications for Placebo-Nocebo Research in Sports.

Angéla Somogyi, Merve Uca, Celal Bulgay, Ernest Yeboah Acheampong, Ricardo de la Vega, Roberto Ruíz-Barquín, Attila Szabo

Abstract read
In one paragraph

Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Angéla SomogyiDepartment of Psychology and Health Management, Faculty of Health and Sport Sciences, Széchényi István University, 9026 Győr, Hungary.
Merve UcaSchool of Physical Education and Sports, Istanbul Esenyurt University, 34510 Istanbul, Türkiye.
Celal BulgaySports Science Faculty, Bingol University, 12000 Bingol, Türkiye.ORCID 0000-0003-4026-9883
Ernest Yeboah AcheampongDepartment of Health, Physical Education, Recreation and Sports, University of Education, Winneba P.O. Box 25, Ghana.ORCID 0000-0002-4352-3149
Ricardo de la VegaDepartment of Physical Education, Sport and Human Movement, Autonomous University of Madrid, 28049 Madrid, Spain.ORCID 0000-0002-7395-3297
Roberto Ruíz-BarquínDepartment of Developmental and Educational Psychology, Autonomous University of Madrid, 28049 Madrid, Spain.ORCID 0000-0002-7149-2685
Attila SzaboDepartment of Psychology and Health Management, Faculty of Health and Sport Sciences, Széchényi István University, 9026 Győr, Hungary.ORCID 0000-0003-2788-4304

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNutritional expectations have been shown to influence exercise performance via placebo and nocebo effects. The present study aimed to evaluate performance-enhancement expectations for coffee and energy drinks using the Stanford Expectations of Treatment Scale.

methodsA total of 402 participants (48.5% male) with an average exercise history of 4.53 years, engaging in average physical activity 3.91 times per week, were included in the study. Data collection was conducted through the Qualtrics platform.

resultsParticipants exhibited significantly higher positive expectations for coffee compared to energy drinks (

conclusionsThe findings suggest that coffee is perceived as a more effective performance enhancer and exhibits greater placebo-inducing potential than energy drinks, which may elicit stronger nocebo effects. These group-specific perceptions should be considered by trainers, coaches, and researchers when addressing placebo-nocebo mechanisms in the context of sports and exercise.

Indexed as

Athletic PerformanceCoffeeEnergy DrinksNocebo EffectPlacebo EffectSportsAdultExerciseFemaleHumansMaleMiddle AgedYoung AdultCoffeeathletecaffeineperformance-enhancementplacebosportstraining

Identifiers

PMID40004957
PMCPMC11858803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.